Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norman R Relkin

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Dementia and Geriatric Cognitive Disorders|April 26, 2003
A large, community-based, open-label trial of donepezil in the treatment of Alzheimer's diseaseNorman R Relkin, William E Reichman, John Orazem, et al.
Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine|January 25, 2003
Assessment of cognitive recovery following sports related head trauma in boxersLisa D Ravdin, William B Barr, Barry Jordan, et al.
Journal of Geriatric Psychiatry and Neurology|November 25, 2005
Genetic risk assessment for adult children of people with Alzheimer's disease: the Risk Evaluation and Education for Alzheimer's Disease (REVEAL) studyJ Scott Roberts, L Adrienne Cupples, Norman R Relkin, et al.
Clinical Neurology and Neurosurgery|March 25, 2008
Features of gait most responsive to tap test in normal pressure hydrocephalusLisa D Ravdin, Heather L Katzen, Anna E Jackson, et al.
Autoimmunity Reviews|December 4, 2012
Alzheimer's disease and Down's syndrome: treating two paths to dementiaMarc E Weksler, Paul Szabo, Norman R Relkin, et al.
Neurology Research International|August 24, 2011
A pilot study of quantitative MRI measurements of ventricular volume and cortical atrophy for the differential diagnosis of normal pressure hydrocephalusDana W Moore, Ilhami Kovanlikaya, Linda A Heier, et al.
Proteomics|September 21, 2007
8-plex quantitation of changes in cerebrospinal fluid protein expression in subjects undergoing intravenous immunoglobulin treatment for Alzheimer's diseaseLeila Choe, Mark D'Ascenzo, Norman R Relkin, et al.
Neurosurgery|December 8, 2010
Postshunt cognitive and functional improvement in idiopathic normal pressure hydrocephalusHeather Katzen, Lisa D Ravdin, Stephanie Assuras, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 19, 2006
Recall of disclosed apolipoprotein E genotype and lifetime risk estimate for Alzheimer's disease: the REVEAL StudySusan LaRusse Eckert, Heather Katzen, J Scott Roberts, et al.
Neurobiology of Aging|February 26, 2008
18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer diseaseNorman R Relkin, Paul Szabo, Basia Adamiak, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Dementia and Geriatric Cognitive Disorders|April 26, 2003
A large, community-based, open-label trial of donepezil in the treatment of Alzheimer's diseaseNorman R Relkin, William E Reichman, John Orazem, et al.
Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine|January 25, 2003
Assessment of cognitive recovery following sports related head trauma in boxersLisa D Ravdin, William B Barr, Barry Jordan, et al.
Journal of Geriatric Psychiatry and Neurology|November 25, 2005
Genetic risk assessment for adult children of people with Alzheimer's disease: the Risk Evaluation and Education for Alzheimer's Disease (REVEAL) studyJ Scott Roberts, L Adrienne Cupples, Norman R Relkin, et al.
Clinical Neurology and Neurosurgery|March 25, 2008
Features of gait most responsive to tap test in normal pressure hydrocephalusLisa D Ravdin, Heather L Katzen, Anna E Jackson, et al.
Autoimmunity Reviews|December 4, 2012
Alzheimer's disease and Down's syndrome: treating two paths to dementiaMarc E Weksler, Paul Szabo, Norman R Relkin, et al.
Neurology Research International|August 24, 2011
A pilot study of quantitative MRI measurements of ventricular volume and cortical atrophy for the differential diagnosis of normal pressure hydrocephalusDana W Moore, Ilhami Kovanlikaya, Linda A Heier, et al.
Proteomics|September 21, 2007
8-plex quantitation of changes in cerebrospinal fluid protein expression in subjects undergoing intravenous immunoglobulin treatment for Alzheimer's diseaseLeila Choe, Mark D'Ascenzo, Norman R Relkin, et al.
Neurosurgery|December 8, 2010
Postshunt cognitive and functional improvement in idiopathic normal pressure hydrocephalusHeather Katzen, Lisa D Ravdin, Stephanie Assuras, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 19, 2006
Recall of disclosed apolipoprotein E genotype and lifetime risk estimate for Alzheimer's disease: the REVEAL StudySusan LaRusse Eckert, Heather Katzen, J Scott Roberts, et al.
Neurobiology of Aging|February 26, 2008
18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer diseaseNorman R Relkin, Paul Szabo, Basia Adamiak, et al.
Pageof 4